Article Details

Eli Lilly to lead oligonucleotide therapy development in new collaboration

Retrieved on: 2025-04-30 14:17:07

Tags for this article:

Click the tags to see associated articles and topics

Eli Lilly to lead oligonucleotide therapy development in new collaboration. View article details on hiswai:

Summary

The article discusses Eli Lilly's partnership with Creyon Bio to develop RNA-targeted oligonucleotide therapies using AI, aligning with the biotech concept. Tags like 'Nucleic acids' and 'Eli Lilly' capture their collaborative research efforts in the U.S.

Article found on: www.europeanpharmaceuticalreview.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo